دورية أكاديمية
أعرض في EDS

Validating the use of Medicare Australia billing data to examine trends in skin cancer.

التفاصيل البيبلوغرافية
العنوان: Validating the use of Medicare Australia billing data to examine trends in skin cancer.
المؤلفون: Perera E; Cancer Council Victoria, Melbourne, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Parkville, Australia; Sinclair Dermatology, Melbourne, Australia., Gnaneswaran N; Plastic Surgery, Royal Brisbane Hospital, Brisbane, Australia., Perera M; School of Medicine, University of Queensland, Brisbane, Australia., Sinclair R; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Parkville, Australia; Sinclair Dermatology, Melbourne, Australia.
المصدر: F1000Research [F1000Res] 2015 Nov 24; Vol. 4, pp. 1341. Date of Electronic Publication: 2015 Nov 24 (Print Publication: 2015).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: F1000 Research Ltd Country of Publication: England NLM ID: 101594320 Publication Model: eCollection Cited Medium: Print ISSN: 2046-1402 (Print) Linking ISSN: 20461402 NLM ISO Abbreviation: F1000Res Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : F1000 Research Ltd
مستخلص: Background:   Epidemiological data surrounding non-melanomatous skin cancer (NMSC) is highly variable, in part due to the lack of government cancer registries. Several studies employ the use of Medical Australia (MA) rebate data in assessing such trends, the validity of which has not been studied in the past. Conversely, melanoma skin cancer is a notifiable disease, and thus, MA and cancer registry data is readily available. The aim of the current study is to assess the use of MA for epidemiological measures for skin cancers, by using melanoma as a disease sample.
Methods:   Following ethics approval, data from MA and Victorian Cancer Registry (VCR) from 2004-2008 were extracted. Incidence of MA and VCR unique melanoma cases were compared and stratified by age and local government area (LGA). Regression and a paired-samples t-test were performed.
Results: During the study period; 15,150 and 13,886 unique melanoma patients were identified through VCR and MA data sources respectively. An outlier in the >80- year age group was noted between MA and VCR data. When stratified by age, significant correlation between MA and VCR was observed for all patients (gradient 0.91, R²= 0.936) and following exclusion of >80 patients (gradient 0.96, R²= 0.995). When stratified by LGA, a high degree of observation was observed for all patients (gradient 0.94, R²= 0.977) and following exclusion of >80 patients (gradient 0.996, R²= 0.975).
Conclusion: Despite the inclusion of outlier data groups, acceptable correlation between MA and VCR melanoma data was observed, suggesting that MA may be suitable for assessing epidemiological trends. Such principals may be used to validate the use of MA data for similar calculations assessing NMSC trends.
References: Health Rep. 1993;5(1):63-6. (PMID: 8334240)
Br J Cancer. 1961 Sep;15:409-24. (PMID: 13876684)
Int J Dermatol. 2002 Oct;41(10):652-8. (PMID: 12390187)
Am J Epidemiol. 1993 Jan 15;137(2):226-34. (PMID: 8452127)
Int J Cancer. 1998 Oct 5;78(2):144-8. (PMID: 9754642)
Med J Aust. 2012 Nov 19;197(10):565-8. (PMID: 23163687)
Med J Aust. 1990 Nov 5;153(9):511-5. (PMID: 2233471)
Int J Cancer. 1993 Feb 20;53(4):585-90. (PMID: 8436431)
Med J Aust. 1963 Mar 2;50(1):312-5. (PMID: 13992964)
Med J Aust. 2006 Jan 2;184(1):6-10. (PMID: 16398622)
Cancer Detect Prev. 2002;26(3):197-202. (PMID: 12269766)
Dermatol Online J. 2014 Feb 18;20(2):. (PMID: 24612576)
Med J Aust. 1990 Apr 16;152(8):399-407. (PMID: 2329947)
Br Med J (Clin Res Ed). 1988 Jan 2;296(6614):13-7. (PMID: 3122913)
J Am Acad Dermatol. 1988 Dec;19(6):1045-52. (PMID: 3204179)
Br J Cancer. 2011 Mar 29;104(7):1227-33. (PMID: 21407221)
Am J Epidemiol. 1996 Dec 1;144(11):1034-40. (PMID: 8942434)
F1000Res. 2014 Aug 05;3:184. (PMID: 25309734)
Med J Aust. 1983 Dec 10-24;2(12):619-22. (PMID: 6669125)
J Am Acad Dermatol. 2014 Jul;71(1):21-6.e1. (PMID: 24685358)
Br J Dermatol. 2011 Nov;165(5):1051-7. (PMID: 21711338)
Br J Cancer. 1961 Sep;15:425-8. (PMID: 13876685)
Med Care. 1999 May;37(5):436-44. (PMID: 10335746)
Int J Cancer. 1997 Nov 27;73(5):629-33. (PMID: 9398037)
J R Soc Health. 1988 Apr;108(2):69-74. (PMID: 3131528)
Int J Cancer. 1993 Apr 1;53(6):886-91. (PMID: 8473047)
Med J Aust. 1989 May 1;150(9):475-8. (PMID: 2786135)
Australas J Dermatol. 1984 Dec;25(3):103-6. (PMID: 6534368)
J Invest Dermatol. 2009 Feb;129(2):323-8. (PMID: 18668137)
J Clin Epidemiol. 2000 Jun;53(6):605-14. (PMID: 10880779)
فهرسة مساهمة: Keywords: Dermatology incidence; Nonmelanoma skin cancer; epidemiology; medicare; melanoma
تواريخ الأحداث: Date Created: 20160304 Date Completed: 20160303 Latest Revision: 20200306
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC4752029
DOI: 10.12688/f1000research.7161.1
PMID: 26937270
قاعدة البيانات: MEDLINE
الوصف
تدمد:2046-1402
DOI:10.12688/f1000research.7161.1